Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bioventus Inc Cl A (BVS)

Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 917,534
  • Shares Outstanding, K 79,166
  • Annual Sales, $ 512,350 K
  • Annual Income, $ -156,230 K
  • 60-Month Beta 0.90
  • Price/Sales 1.77
  • Price/Cash Flow 14.85
  • Price/Book 5.03
Trade BVS with:

Options Overview Details

View History
  • Implied Volatility 92.02% ( -3.99%)
  • Historical Volatility 48.44%
  • IV Percentile 45%
  • IV Rank 35.14%
  • IV High 195.98% on 07/19/24
  • IV Low 35.70% on 05/21/24
  • Put/Call Vol Ratio 1.14
  • Today's Volume 47
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 5,122
  • Open Int (30-Day) 5,127

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.06
  • Number of Estimates 1
  • High Estimate 0.06
  • Low Estimate 0.06
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.01 +14.54%
on 09/11/24
12.41 -7.57%
on 09/27/24
+0.97 (+9.24%)
since 09/09/24
3-Month
5.87 +95.40%
on 07/10/24
12.41 -7.57%
on 09/27/24
+5.17 (+82.06%)
since 07/09/24
52-Week
2.85 +302.46%
on 10/13/23
12.41 -7.57%
on 09/27/24
+8.12 (+242.39%)
since 10/09/23

Most Recent Stories

More News
Here's Why Investors Should Consider Buying Corcept Stock Now

Corcept Therapeutics’ CORT sole-marketed drug, Korlym (mifepristone), which is approved for treating Cushing's syndrome, has been performing well. The drug has been witnessing strong demand in the past...

CORT : 45.94 (+0.35%)
KRYS : 171.98 (-1.64%)
ANIP : 56.73 (-0.11%)
BVS : 11.47 (-1.04%)
Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

For Immediate ReleaseChicago, IL – September 24, 2024 – Stocks in this week’s article are Bioventus Inc. BVS, Great Lakes Dredge & Dock Corp. GLDD and AxoGen, Inc. AXGN.First September Gains in 5...

AXGN : 13.73 (+0.88%)
GLDD : 11.62 (-0.09%)
BVS : 11.47 (-1.04%)
First September Gains in 5 Years? Buy 3 Breakout Stocks Now

September has always been the worst month for the stock market. In early September, stocks gyrated as investors were concerned about a cooling U.S. economy. However, things have begun to improve following...

AXGN : 13.73 (+0.88%)
GLDD : 11.62 (-0.09%)
BVS : 11.47 (-1.04%)
SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bioventus Inc. of Class Action Lawsuit and Upcoming Deadline - BVS

/PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bioventus Inc. ("Bioventus" or the "Company") (NASDAQ: BVS) and...

BVS : 11.47 (-1.04%)
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Bioventus Inc. (BVS) Investors of Class Action and Last Few Hours to Actively Participate

Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Bioventus Inc. (“Bioventus” or the “Company”) (NASDAQ: BVS) and certain...

BVS : 11.47 (-1.04%)
BIOVENTUS SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Bioventus To Contact Him Directly To Discuss Their Options

/PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Bioventus Inc. ("Bioventus" or the...

BVS : 11.47 (-1.04%)
BIOVENTUS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bioventus Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Bioventus Inc. (“Bioventus” or the “Company”)...

BVS : 11.47 (-1.04%)
BVS DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Bioventus Inc. (NASDAQ: BVS): (i) pursuant and/or...

BVS : 11.47 (-1.04%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

The Law Offices of Frank R. Cruz reminds investors of the upcoming March 13, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Bioventus Inc....

BVS : 11.47 (-1.04%)
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bioventus Inc. (BVS)

/PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming March 13, 2023 deadline to file a lead plaintiff motion in the class...

BVS : 11.47 (-1.04%)

Business Summary

Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.

See More

Key Turning Points

3rd Resistance Point 11.90
2nd Resistance Point 11.72
1st Resistance Point 11.60
Last Price 11.47
1st Support Level 11.30
2nd Support Level 11.12
3rd Support Level 11.00

See More

52-Week High 12.41
Last Price 11.47
Fibonacci 61.8% 8.76
Fibonacci 50% 7.63
Fibonacci 38.2% 6.50
52-Week Low 2.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar